MicroRNA 3663 (MIR3663)

MicroRNA 3663 (MIR3663) is a small, non-coding RNA molecule belonging to the microRNA (miRNA) family. These molecules are typically 20–24 nucleotides long and function primarily to **regulate gene expression post-transcriptionally** in multicellular organisms. They are generated from a primary transcript through a series of processing steps involving Drosha and Dicer enzymes to yield a mature miRNA, which is loaded into a RISC complex. The primary function of miRNAs, including MIR3663, is to guide RISC to complementary mRNA molecules, most commonly resulting in **translational repression or mRNA destabilization**. MIR3663, like other miRNAs, is implied in cellular processes such as cell proliferation and differentiation by regulating various target mRNAs. Although the general role of miRNAs in disease biology is well established, specific functional or pathological roles for MIR3663 have not been widely documented; one report links it to telangiectatic osteogenic sarcoma[1][7][4]. Currently, there are no known drugs directly targeting MIR3663, nor is it established as a diagnostic or therapeutic biomarker. Key points: - MIR3663 is a member of the microRNA family, a broad class of non-coding RNAs with major roles in **post-transcriptional gene silencing**. - It is **not** a classical therapeutic target (such as a receptor, enzyme, or transporter) but a regulatory RNA[1][7]. - For more detailed, context-specific roles, functional studies or expression profiling would be necessary, as specific disease or molecular pathway links for MIR3663 are limited in current literature.

Other names

hsa-mir-3663MIR3663hsa-mir-3663-1hsa-mir-3663-2

No drugs known to act directly on MIR3663; general miRNA mechanisms include mRNA silencing via RISC complex.